Cilostazol in secondary prevention of stroke: Impact of the Cilostazol Stroke Prevention Study
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 6 (4) , 33-40
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Trends in the Incidence, Mortality, and Survival Rate of Cardiovascular Disease in a Japanese CommunityStroke, 2003
- Hospital-Based Study of the Care and Cost of Acute Ischemic Stroke in JapanStroke, 2003
- A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetesDiabetologia, 2002
- Changes in Stroke Mortality Rates for 1950 to 1997Stroke, 2001
- Incidence and Risk Factors for Subtypes of Cerebral Infarction in a General PopulationStroke, 2000
- International Trends in Mortality From Stroke, 1968 to 1994Stroke, 2000
- Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarctionJournal of Stroke and Cerebrovascular Diseases, 2000
- Aspirin and Risk of Hemorrhagic StrokeJAMA, 1998
- The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary EventsAnnals of Internal Medicine, 1998
- Sex and Time Trends in Cardiovascular Disease Incidence and Mortality: the Framingham Heart Study, 1950-1989American Journal of Epidemiology, 1996